197 related articles for article (PubMed ID: 27839905)
21. Genetic analysis of the CHCHD2 gene in a cohort of Chinese patients with Parkinson disease.
Wu H; Lu X; Xie F; Cen Z; Zheng X; Luo W
Neurosci Lett; 2016 Aug; 629():116-118. PubMed ID: 27353515
[TBL] [Abstract][Full Text] [Related]
22. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
23. Genetic screening of Filipinos suspected with familial Parkinson's disease: A pilot study.
Caritativo ECA; Yu JRT; Bautista JMP; Nishioka K; Jamora RDG; Yalung PM; Ng AR; Hattori N
Parkinsonism Relat Disord; 2023 Mar; 108():105319. PubMed ID: 36774704
[TBL] [Abstract][Full Text] [Related]
24. Mutations in CHCHD2 cause α-synuclein aggregation.
Ikeda A; Nishioka K; Meng H; Takanashi M; Hasegawa I; Inoshita T; Shiba-Fukushima K; Li Y; Yoshino H; Mori A; Okuzumi A; Yamaguchi A; Nonaka R; Izawa N; Ishikawa KI; Saiki H; Morita M; Hasegawa M; Hasegawa K; Elahi M; Funayama M; Okano H; Akamatsu W; Imai Y; Hattori N
Hum Mol Genet; 2019 Dec; 28(23):3895-3911. PubMed ID: 31600778
[TBL] [Abstract][Full Text] [Related]
25. Brain glucose metabolism changes in Parkinson's disease patients with CHCHD2 mutation based on (18)F-FDG PET imaging.
Mao CY; Wu P; Zhang SY; Yang J; Liu YT; Zuo CT; Zhuang ZP; Shi CH; Xu YM
J Neurol Sci; 2016 Oct; 369():303-305. PubMed ID: 27653913
[No Abstract] [Full Text] [Related]
26. CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10.
Huang X; Wu BP; Nguyen D; Liu YT; Marani M; Hench J; Bénit P; Kozjak-Pavlovic V; Rustin P; Frank S; Narendra DP
Hum Mol Genet; 2018 Nov; 27(22):3881-3900. PubMed ID: 30084972
[TBL] [Abstract][Full Text] [Related]
27. Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson's disease.
Liu X; Wang Q; Yang Y; Stewart T; Shi M; Soltys D; Liu G; Thorland E; Cilento EM; Hou Y; Liu Z; Feng T; Zhang J
Acta Neuropathol Commun; 2021 Mar; 9(1):37. PubMed ID: 33685516
[TBL] [Abstract][Full Text] [Related]
28. Mutation analysis of the CHCHD2 gene in Chinese Han patients with Parkinson's disease.
Lu Q; Deng X; Song Z; Guo Y; Yang Y; Deng H
Parkinsonism Relat Disord; 2016 Aug; 29():143-4. PubMed ID: 27118487
[No Abstract] [Full Text] [Related]
29. New Genes Causing Hereditary Parkinson's Disease or Parkinsonism.
Puschmann A
Curr Neurol Neurosci Rep; 2017 Sep; 17(9):66. PubMed ID: 28733970
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders.
Ogaki K; Koga S; Heckman MG; Fiesel FC; Ando M; Labbé C; Lorenzo-Betancor O; Moussaud-Lamodière EL; Soto-Ortolaza AI; Walton RL; Strongosky AJ; Uitti RJ; McCarthy A; Lynch T; Siuda J; Opala G; Rudzinska M; Krygowska-Wajs A; Barcikowska M; Czyzewski K; Puschmann A; Nishioka K; Funayama M; Hattori N; Parisi JE; Petersen RC; Graff-Radford NR; Boeve BF; Springer W; Wszolek ZK; Dickson DW; Ross OA
Neurology; 2015 Dec; 85(23):2016-25. PubMed ID: 26561290
[TBL] [Abstract][Full Text] [Related]
31. CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy.
Shammas MK; Huang TH; Narendra DP
Biochem Soc Trans; 2023 Apr; 51(2):797-809. PubMed ID: 37021679
[TBL] [Abstract][Full Text] [Related]
32. The mutation spectrum of Parkinson-disease-related genes in early-onset Parkinson's disease in ethnic Chinese.
Chen YP; Yu SH; Zhang GH; Hou YB; Gu XJ; Ou RW; Shen Y; Song W; Chen XP; Zhao B; Cao B; Zhang LY; Sun MM; Liu FF; Wei QQ; Liu KC; Lin JY; Yang TM; Yang J; Wu Y; Jiang Z; Liu J; Cheng YF; Xiao Y; Su WM; Feng F; Cai YY; Li SR; Hu T; Yuan XQ; Zhou QQ; Shao N; Ma S; Shang HF
Eur J Neurol; 2022 Nov; 29(11):3218-3228. PubMed ID: 35861376
[TBL] [Abstract][Full Text] [Related]
33. Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c.
Meng H; Yamashita C; Shiba-Fukushima K; Inoshita T; Funayama M; Sato S; Hatta T; Natsume T; Umitsu M; Takagi J; Imai Y; Hattori N
Nat Commun; 2017 Jun; 8():15500. PubMed ID: 28589937
[TBL] [Abstract][Full Text] [Related]
34. Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2.
Torii S; Arakawa S; Sato S; Ishikawa KI; Taniguchi D; Sakurai HT; Honda S; Hiraoka Y; Ono M; Akamatsu W; Hattori N; Shimizu S
EMBO Mol Med; 2023 Sep; 15(9):e17451. PubMed ID: 37578019
[TBL] [Abstract][Full Text] [Related]
35. CHCHD2 and Parkinson's disease.
Foo JN; Liu J; Tan EK
Lancet Neurol; 2015 Jul; 14(7):681-2. PubMed ID: 26067114
[No Abstract] [Full Text] [Related]
36. CHCHD2 and Parkinson's disease.
Iqbal Z; Toft M
Lancet Neurol; 2015 Jul; 14(7):680-1. PubMed ID: 26067113
[No Abstract] [Full Text] [Related]
37. CHCHD2 and Parkinson's disease.
Liu G; Li K
Lancet Neurol; 2015 Jul; 14(7):679-80. PubMed ID: 26067112
[No Abstract] [Full Text] [Related]
38. CHCHD2 and Parkinson's disease.
Puschmann A; Dickson DW; Englund E; Wszolek ZK; Ross OA
Lancet Neurol; 2015 Jul; 14(7):679. PubMed ID: 26067111
[No Abstract] [Full Text] [Related]
39. CHCHD2 p.Thr61Ile knock-in mice exhibit motor defects and neuropathological features of Parkinson's disease.
Fan L; Zhang S; Li X; Hu Z; Yang J; Zhang S; Zheng H; Su Y; Luo H; Liu X; Fan Y; Sun H; Zhang Z; Miao J; Song B; Xia Z; Shi C; Mao C; Xu Y
Brain Pathol; 2023 May; 33(3):e13124. PubMed ID: 36322611
[TBL] [Abstract][Full Text] [Related]
40. CHCHD2 and Parkinson's disease--authors' reply.
Funayama M; Hattori N
Lancet Neurol; 2015 Jul; 14(7):682-3. PubMed ID: 26067115
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
